POINT
PNTPOINT Biopharma Price (PNT)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
96,034,506
(30.0385)%Cash Flow Statement
POINT Biopharma Global Inc.Currency: USD
| YEAR | 2019 | 2020 | 2021 | 2022 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -36,896.00
+0% |
-13,373,003.00
+36,145% |
-45,902,481.00
+243% |
98.29M
-314% |
|||||||||||||||
| Depreciation And Amortiz... | 0.00 | 0.00 | 11.84k | 1.40M | |||||||||||||||
| Deferred Income Tax | 0.00 | 0.00 | 65.59k | 1.39M | |||||||||||||||
| Stock-Based Compensat... | 0.00 | 1.76M | 2.30M | 3.55M | |||||||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Accounts Payables | 0.00 | 3.60M | -2,022,472.00 | 4.83M | |||||||||||||||
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Other Working Capital | 0.00 | -292,647.00 | 846.16k | 76.03M | |||||||||||||||
| Other Non-Cash Items | 36.90k | 5.35k | 0.00 | -1,953,604.00 | |||||||||||||||
| Net Cash Provided By Op... | 0.00
+0% |
-8,302,856.00
+0% |
-44,698,758.00
+438% |
183.52M
-511% |
|||||||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | 0.00 | -9,797,400.00 | -8,802,182.00 | -12,766,522.00 | |||||||||||||||
| Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Purchases Of Investments | 0.00 | 0.00 | 0.00 | -253,498,464.00 | |||||||||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Net Cash Used For Inv... | 0.00
+0% |
-9,797,400.00
+0% |
-8,802,182.00
-10% |
-266,264,986.00
+2,925% |
|||||||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Common Stock Issued | 0.00 | 25.43M | 264.88M | 130.31M | |||||||||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Other Financing Activities | 0.00 | 28.65M | 281.77M | 130.36M | |||||||||||||||
| Net Cash Used/Provide... | 0.00
+0% |
28.65M
+0% |
281.77M
+884% |
130.36M
-54% |
|||||||||||||||
| Effect Of Forex Changes... | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Net Change In Cash | 0.00 | 10.55M | 228.27M | 47.61M | |||||||||||||||
| Cash At Beginning Of Per... | 0.00 | 0.00 | 10.55M | 238.82M | |||||||||||||||
| Cash At End Of Period | 0.00 | 10.55M | 238.82M | 286.43M | |||||||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | 0.00 | -8,302,856.00 | -44,698,758.00 | 183.52M | |||||||||||||||
| Capital Expenditure | 0.00 | -9,797,400.00 | -8,802,182.00 | -12,766,522.00 | |||||||||||||||
| Free Cash Flow | 0.00
+0% |
-18,100,256.00
+0% |
-53,500,940.00
+196% |
170.75M
-419% |
|||||||||||||||